RT Journal Article SR Electronic T1 Combination of the CD8+:B-cell and Neutrophil-to-Lymphocyte Ratio as a Novel Prediction Model for Intubation Need and Disease Severity in COVID-19 Patients JF In Vivo JO In Vivo FD International Institute of Anticancer Research SP 3305 OP 3313 DO 10.21873/invivo.12626 VO 35 IS 6 A1 MARIA G. DETSIKA A1 EIRINI GRIGORIOU A1 KATHERINA PSARRA A1 EDISON JAHAJ A1 STAMATIOS TSIPILIS A1 NIKOLAOS ATHANASSIOU A1 ALEXANDROS ZACHARIS A1 IOANNA DIMOPOULOU A1 STYLIANOS E. ORFANOS A1 ALEXANDRA TSIROGIANNI A1 ANASTASIA KOTANIDOU YR 2021 UL http://iv.iiarjournals.org/content/35/6/3305.abstract AB Background: The study provides a novel prediction model for COVID-19 progression and outcome by the combination of the CD8+: B-cells ratio with neutrophil-to-lymphocyte ratio (NLR). Patients and Methods: Immune phenotyping was performed in 120 COVID-19 patients. Results: A decrease in CD8+:B-cell (p<0.0001) and in lymphocyte-to-CRP (LCR) ratio (p<0.0001) was observed in intubated patients versus non-intubated with an increase for CD4+:CD8+ (p<0.01), NLR (p<0.0001) and CRP: Albumin (p<0.001). Receiving operating curve (ROC) analysis predicting requirement for mechanical ventilation revealed the highest AUC for CD8+:B-cells, (AUC=0.795, p<0.001) versus NLR (AUC=0.783, p<0.001), LCR (AUC=0.779, p<0.001), Albumin:CRP (AUC=0.750, p<0.001) and CD4+:CD8+ (AUC=0.779, p<0.001). Combination of the CD8+: B-cell ratio with the NLR increased the AUC (AUC=0.845, p<0.001). The combined ratios correlated with outcome defined as duration of hospital (r=0.435, p<0.001) or ICU stay (r=0.596, p<0.001). Conclusion: Combination of the CD8+: B-cell ratio and NLR serves as a useful prognostic tool for COVID-19 patient progression.